Home X-Chem Licenses Cardiovascular Drug Discovery Program To Bayer Pharma AG
 

Keywords :   


X-Chem Licenses Cardiovascular Drug Discovery Program To Bayer Pharma AG

2014-12-29 01:28:39| drugdiscoveryonline Home Page

X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, recently announced it has licensed a second drug discovery program to Bayer Pharma AG pursuant to the multi-target collaboration the companies established in July 2012

Tags: program drug discovery licenses

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »